Effect of micronutrients on behavior and mood in adults With ADHD: evidence from an 8-week open label trial with natural extension (Q42645625)

4 November 2017

Effect of micronutrients on behavior and mood in adults With ADHD: evidence from an 8-week open label trial with natural extension (English)

1 reference

4 November 2017

1

1 reference

4 November 2017

Mairin Taylor

2

0 references

author name string

Kathryn Whitehead

series ordinal

3

1 reference

4 November 2017

13 January 2010

1 reference

Journal of Attention Disorders

4 November 2017

1 reference

4 November 2017

15

1 reference

4 November 2017

1

1 reference

4 November 2017

79-91

1 reference

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]

4 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

ADHD prevalence in adult outpatients with nonpsychotic psychiatric illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Practitioner review: the assessment of bipolar disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Alternative and controversial treatments for attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Response style differences in the inattentive and combined subtypes of attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Vitamins, minerals, and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Treatment of mood lability and explosive rage with minerals and vitamins: two case studies in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Improved mood and behavior during treatment with a mineral-vitamin supplement: an open-label case series of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Methylphenidate effects on symptoms of attention deficit disorder in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Is ADHD a disinhibitory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Hematologic side effects of psychotropics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Emotional dysregulation in adult ADHD and response to atomoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Successful treatment of OCD with a micronutrient formula following partial response to Cognitive Behavioral Therapy (CBT): a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Nutrient supplementation approaches in the treatment of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Abnormal glucose metabolism in patients treated with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Treatment of adult ADHD: is current knowledge useful to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a Lactobacillus plantarum with anti-Candida activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709356173

21 January 2018

Identifiers

DOI

10.1177/1087054709356173

1 reference

4 November 2017

1 reference

PubMed ID

20071638